Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall (DIGNITY)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Celsion
Sponsor:
Information provided by (Responsible Party):
Celsion
ClinicalTrials.gov Identifier:
NCT00826085
First received: January 19, 2009
Last updated: October 10, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
No publications provided by Celsion

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):